Therapeutic apheresis procedure targeting platelet depletion (plateletpheresis) in a patient with a pathologic excess of circulating platelets.
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $88.18
- Work RVU
- 1.95
- Global, days
- 0
- Region
- General
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Diagnosis driving platelet depletion (e.g., essential thrombocythemia, reactive thrombocytosis) with corresponding ICD-10 code
- Physician order specifying therapeutic plateletpheresis and clinical indication
- Platelet count before and after the procedure to demonstrate medical necessity and response
- Documentation that this is a therapeutic (patient treatment) procedure, not donor platelet collection
- If same-day E/M is billed, documentation that the visit addressed a separately identifiable problem with a distinct diagnosis
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 36513 describes therapeutic plateletpheresis — an extracorporeal procedure that selectively removes platelets from a patient's blood to treat conditions such as thrombocythemia or extreme thrombocytosis. Blood is drawn, passed through an apheresis device that isolates and removes platelets, and the remaining components are returned to the patient. This is a therapeutic intervention, not a donor collection procedure; 36513 does not apply to collecting donor platelets for transfusion.
The code carries a 000-day global period, meaning each session is billed independently with no bundled pre- or post-procedure care attached. In the outpatient hospital setting, CMS assigns this to APC 5241 (Level 1 Blood Product Exchange). A physician may bill a same-day E/M only when the visit is for a separately identifiable service tied to a different diagnosis — append modifier 25 to the E/M in that scenario.
UnitedHealthcare's 2026 commercial policy lists specific covered diagnoses for therapeutic apheresis. Thrombocytosis and related platelet-excess conditions must be clearly documented with supporting ICD-10 codes to clear medical necessity review. Payers vary on whether prior authorization is required per session or per treatment course; verify before scheduling.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
Work RVU vs. total RVU
The work RVU (1.95) is the surgeon's own effort — the figure physician pay and productivity targets are built on. The total RVU (2.64) adds practice overhead and malpractice, and is what drives the Medicare payment below.
| Work RVU | 1.95 |
| Practice expense RVU | 0.53 |
| Malpractice RVU | 0.16 |
| Total RVU | 2.64 |
| Medicare national rate | $88.18 |
| Global period | 0 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $88.18 |
HOPD (APC 5241) Hospital outpatient department | $450.73 |
ASC (PI R2) Ambulatory surgical center (freestanding) | $244.40 |
Common denial reasons
The recurring reasons claims for CPT 36513 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Medical necessity not established — payer requires specific covered diagnosis and 36513 is billed with an unsupported or vague ICD-10 code
- Conflation with donor platelet collection — 36513 does not cover apheresis performed to collect platelets for transfusion to another patient
- Same-day E/M denied when the visit note does not clearly separate it from the supervision of the apheresis procedure itself
- Missing or expired prior authorization — many commercial payers require auth per treatment course for therapeutic apheresis
- Bundling denial when billed alongside codes that are NCCI-edit column 2 components of the apheresis service without an appropriate modifier
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Can 36513 be used when collecting platelets from a donor for transfusion?
02What global period applies to 36513?
03Can a physician bill an E/M on the same day as supervising a 36513 procedure?
04Which ICD-10 diagnoses support medical necessity for 36513?
05Does 36513 require prior authorization?
06When is modifier 76 appropriate with 36513?
07How does site of service affect reimbursement for 36513?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02terumobct.comhttps://www.terumobct.com/content/dam/terumo-bct/local-documents/veeva-unlinked/support/product-support/2025%20Final%20Published%20ASFA_Therapeutic_Apheresis_Reimbursement_Guide_2025.pdf
- 03uhcprovider.comhttps://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/apheresis.pdf
- 04cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 05cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
Mira Scribe
Mira's AI scribe captures the clinical indication for platelet depletion (diagnosis, current platelet count, prior treatment history), the treating physician's supervision role, and whether any separately identifiable E/M service was rendered for a distinct diagnosis on the same date. That documentation chain directly prevents the two most common denials: unsupported medical necessity and same-day E/M bundling.
See how Mira captures CPT 36513 documentation